HK Stock Market Move | Concept stocks of commercial aerospace companies rose across the board today. SpaceX is expected to complete its IPO next month, with a potential market value reaching as high as $2 trillion.
Commercial aerospace concept stocks rose across the board today. As of the time of writing, Blue Signal Technology (06613) rose by 6.54% to HK$21.5; Junda Co., Ltd (02865) rose by 4.15% to HK$40.12; Asia Pacific Satellite (01045) rose by 2.81% to HK$3.29; and Goldwind Technology (02208) rose by 1.89% to HK$14.58.
Concept stocks in the commercial aerospace sector rose across the board today, as of the time of publication, Lens Technology (06613) rose 6.54% to 21.5 Hong Kong dollars; Hainan Drinda New Energy Technology (02865) rose 4.15% to 40.12 Hong Kong dollars; APT SATELLITE (01045) rose 2.81% to 3.29 Hong Kong dollars; Goldwind Science & Technology (02208) rose 1.89% to 14.58 Hong Kong dollars.
In terms of news, it is reported that SpaceX plans to complete its IPO on June 12, with a target fundraising scale of 80 billion USD and an initial estimated valuation of around 2 trillion USD. There is market expectation that this IPO will significantly impact the valuation of the domestic commercial aerospace industry, and the breakthrough of SpaceX's Starlink business users and strategic directions like AI satellite constellation further strengthen the industry logic of satellite internet and space economy.
Huaxi mentioned that China's rocket and satellite industry chain is complete, the path for commercial aerospace collaboration is clear, and with mature rocket recycling technology and optimized rocket launch costs, the industry is expected to enter a rapid growth phase under the exploration of constellation network demands and terminal consumer paths. Companies up and down the industry chain are expected to benefit as a whole; the recent SpaceX listing catalyzes the continuous benefits of the commercial aerospace sector.
Related Articles

New Stock News | Rongtai Pharmaceutical submits a second application to the Hong Kong Stock Exchange, becoming China's third-largest provider of digital marketing and supply chain services for the outpatient pharmaceutical market.

New IPO news: Xiangdao Travel submitted a second application to the Hong Kong Stock Exchange, attracting key industry chain investors such as Momenta, Gaode, and Contemporary Amperex Technology.

New Stock News | Innovative biopharmaceutical company Sinocelltech Inc. (688520.SH) files for listing on the Hong Kong Stock Exchange with a gross profit margin of over 90% for three consecutive years.
New Stock News | Rongtai Pharmaceutical submits a second application to the Hong Kong Stock Exchange, becoming China's third-largest provider of digital marketing and supply chain services for the outpatient pharmaceutical market.

New IPO news: Xiangdao Travel submitted a second application to the Hong Kong Stock Exchange, attracting key industry chain investors such as Momenta, Gaode, and Contemporary Amperex Technology.

New Stock News | Innovative biopharmaceutical company Sinocelltech Inc. (688520.SH) files for listing on the Hong Kong Stock Exchange with a gross profit margin of over 90% for three consecutive years.






